The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Interferon-α But Not AZT Suppresses HIV Expression in Chronically Infected Cell Lines
Abstract
Promonocytic (U1) and T lymphocytic (ACH-2) cell lines chronically infected with human immunodeficiency virus type 1 (HIV-1) constitutively express low levels of virus, but expression can be induced by phorbol esters and cytokines. Whereas ACH-2 cells produce infectious virions, U1 cells produce defective, noninfectious particles. Although 3′-azido-3′-deoxythimidine (AZT) prevented acute HIV infection of susceptible cells, it did not prevent the induction of HIV expression in the infected cell lines. In contrast, interferon alpha (IFN-α) inhibited the release of reverse transcriptase and viral antigens into the culture supernatant after phorbol ester stimulation of both cell lines. Further, IFN-α suppressed the production or release (or both) of whole HIV virions, but had no effect on the amount of cell-associated viral proteins. Also, after phorbol ester stimulation of ACH-2 cells, IFN-α reduced the number of infectious viral particles secreted into the culture supernatant, but had no effect on the infectivity of cell-associated virus. These findings lend support to the combined use of antiviral agents that have action at both the early (AZT) and the late (IFN-α) stages of HIV replication.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Efficacy of Azidothymidine (AZT) in the Treatment of Patients with AIDS and AIDS-Related Complex
Fischl, M. A., Richman, D. D., Grieco, M. H., Gottlieb, M. S., Volberding, P. A., Laskin, O. L., Leedom, J. M., Groopman, J. E., Mildvan, D., Schooley, R. T., et al. (1987) · New England Journal of Medicine · doi:10.1056/nejm198707233170401 · Cited by 2,995
An inducible transcription factor activates expression of human immunodeficiency virus in T cells
Nabel, G., & Baltimore, D. (1987) · Nature · doi:10.1038/326711a0 · Cited by 2,041
The Role of Mononuclear Phagocytes in HTLV-III/LAV Infection
Gartner, S., Markovits, P., Markovitz, D. M., Kaplan, M. H., Gallo, R. C., & Popovic, M. (1986) · Science · doi:10.1126/science.3014648 · Cited by 1,807
Lane, H. C., Masur, H., Edgar, L. C., Whalen, G., Rook, A. H., & Fauci, A. S. (1983) · New England Journal of Medicine · doi:10.1056/nejm198308253090803 · Cited by 1,600
Self-citationThe Human Immunodeficiency Virus: Infectivity and Mechanisms of Pathogenesis
Fauci, A. S. (1988) · Science · doi:10.1126/science.3277274 · Cited by 1,486
Self-citationCytokine-Induced Expression of HIV-1 in a Chronically Infected Promonocyte Cell Line
Folks, T. M., Justement, J., Kinter, A., Dinarello, C. A., & Fauci, A. S. (1987) · Science · doi:10.1126/science.3313729 · Cited by 905
Self-citationGendelman, H. E., Orenstein, J. M., Martin, M. A., Ferrua, C., Mitra, R., Phipps, T., Wahl, L. A., Lane, H. C., Fauci, A. S., & Burke, D. S. (1988) · The Journal of experimental medicine · doi:10.1084/jem.167.4.1428 · Cited by 781
Self-citationWilley, R. L., Smith, D. H., Lasky, L. A., Theodore, T. S., Earl, P. L., Moss, B., Capon, D. J., & Martin, M. A. (1988) · Journal of Virology · doi:10.1128/jvi.62.1.139-147.1988 · Cited by 751
Folks, T. M., Clouse, K. A., Justement, J., Rabson, A., Duh, E., Kehrl, J. H., & Fauci, A. S. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.7.2365 · Cited by 712
Self-citationActivation of the AIDS Retrovirus Promoter by the Cellular Transcription Factor, Sp1
Jones, K. A., Kadonaga, J. T., Luciw, P. A., & Tjian, R. (1986) · Science · doi:10.1126/science.3008338 · Cited by 701
Infection of monocyte/macrophages by human T lymphotropic virus type III.
Ho, D. D., Rota, T. R., & Hirsch, M. S. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112491 · Cited by 672
Clouse, K. A., Powell, D., Washington, I., Poli, G., Strebel, K., Farrar, W., Barstad, P., Kovacs, J., Fauci, A. S., & Folks, T. M. (1989) · The Journal of Immunology · doi:10.4049/jimmunol.142.2.431 · Cited by 542
Self-citationZagury, D., Bernard, J., Leonard, R., Cheynier, R., Feldman, M., Sarin, P. S., & Gallo, R. C. (1986) · Science · doi:10.1126/science.2418502 · Cited by 530
Strategies for antiviral therapy in AIDS
Mitsuya, H., & Broder, S. (1987) · Nature · doi:10.1038/325773a0 · Cited by 487
A Novel Gene of HIV-1, vpu , and Its 16-Kilodalton Product
Strebel, K., Klimkait, T., & Martin, M. A. (1988) · Science · doi:10.1126/science.3261888 · Cited by 447
Folks, T. M., Powell, D., Lightfoote, M., Koenig, S., Fauci, A. S., Benn, S., Rabson, A., Daugherty, D., Gendelman, H. E., & Hoggan, M. D. (1986) · The Journal of experimental medicine · doi:10.1084/jem.164.1.280 · Cited by 418
Self-citationSiliciano, R. F., Lawton, T., Knall, C., Karr, R. W., Berman, P., Gregory, T., & Reinherz, E. L. (1988) · Cell · doi:10.1016/0092-8674(88)90078-5 · Cited by 369
Direct Polyclonal Activation of Human B Lymphocytes by the Acquired Immune Deficiency Syndrome Virus
Schnittman, S. M., Lane, H. C., Higgins, S. E., Folks, T., & Fauci, A. S. (1986) · Science · doi:10.1126/science.3016902 · Cited by 364
Self-citationTrans-activation of the human immunodeficiency virus long terminal repeat sequence by DNA viruses.
Gendelman, H. E., Phelps, W., Feigenbaum, L., Ostrove, J. M., Adachi, A., Howley, P. M., Khoury, G., Ginsberg, H. S., & Martin, M. A. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.24.9759 · Cited by 362
Yarchoan, R., Brouwers, P., Robert Spitzer, A., Grafman, J., Safai, B., Perno, C., Larson, S., Berg, G., Fischl, M., Wichman, A., et al. (1987) · The Lancet · doi:10.1016/s0140-6736(87)91968-4 · Cited by 352
Montagnier, L., Gruest, J., Chamaret, S., Dauguet, C., Axler-Blin, C., Guétard, D., Nugeyre, M.-T., Barré‐Sinoussi, F., Chermann, J., Brunet, J., et al. (1984) · Science · doi:10.1126/science.6328661 · Cited by 349
Nicholson, J. K. A., Cross, G. D., Callaway, C. S., & McDougal, J. S. (1986) · The Journal of Immunology · doi:10.4049/jimmunol.137.1.323 · Cited by 336
Immunologic abnormalities in homosexual men
Stahl, R. E., Friedman-Kien, A., Dubin, R., Marmor, M., & Zolla-Pazner, S. (1982) · The American Journal of Medicine · doi:10.1016/0002-9343(82)90174-7 · Cited by 318
Folks, T. M., Justement, J., Kinter, A., Schnittman, S., Orenstein, J., Poli, G., & Fauci, A. S. (1988) · The Journal of Immunology · doi:10.4049/jimmunol.140.4.1117 · Cited by 315
Self-citationRECOMBINANT HUMAN INTERFERON ALFA-A SUPPRESSES HTLV-III REPLICATION IN VITRO
Ho, D., Rota, T., Kaplan, J., Hartshorn, K., Andrews, C., Schooley, R., & Hirsch, M. (1985) · The Lancet · doi:10.1016/s0140-6736(85)92144-0 · Cited by 305
Herpes simplex virus type-1 can reactivate transcription of latent human immunodeficiency virus
Mosca, J. D., Bednarik, D. P., Raj, N. B. K., Rosen, C. A., Sodroski, J. G., Haseltine, W. A., & Pitha, P. M. (1987) · Nature · doi:10.1038/325067a0 · Cited by 303
T cells can present antigens such as HIV gp120 targeted to their own surface molecules
Lanzavecchia, A., Roosnek, E., Gregory, T., Berman, P., & Abrignani, S. (1988) · Nature · doi:10.1038/334530a0 · Cited by 291
Monocyte function in the acquired immune deficiency syndrome. Defective chemotaxis.
Smith, P. D., Ohura, K., Masur, H., Lane, H. C., Fauci, A. S., & Wahl, S. M. (1984) · Journal of Clinical Investigation · doi:10.1172/jci111637 · Cited by 287
Self-citationBidirectional Interactions Between Human Immunodeficiency Virus Type 1 and Cytomegalovirus
Skolnik, P. R., Kosloff, B. R., & Hirsch, M. S. (1988) · Journal of Infectious Diseases · doi:10.1093/infdis/157.3.508 · Cited by 271
ANTI-RETROVIRAL EFFECTS OF INTERFERON-α IN AIDS-ASSOCIATED KAPOSI'S SARCOMA
Clifford Lane, H., Feinberg, J., Davey, V., Deyton, L., Baseler, M., Manischewitz, J., Masur, H., Kovacs, J., Herpin, B., Walker, R., et al. (1988) · The Lancet · doi:10.1016/s0140-6736(88)90811-2 · Cited by 261
Self-citationSEPTICÆMIA DUE TO PORCINE STREPTOCOCCI
Kloppenburg, M., Mulder, N. H., & Houwerzijl, J. (1975) · The Lancet · doi:10.1016/s0140-6736(75)92719-1 · Cited by 212
Margolick, J. B., Volkman, D. J., Folks, T. M., & Fauci, A. S. (1987) · The Journal of Immunology · doi:10.4049/jimmunol.138.6.1719 · Cited by 191
Self-citationSusceptibility of normal human lymphocytes to infection with HTLV-III/LAV.
Folks, T., Kelly, J., Benn, S., Kinter, A., Justement, J., Gold, J., Redfield, R., Sell, K. W., & Fauci, A. S. (1986) · The Journal of Immunology · doi:10.4049/jimmunol.136.11.4049 · Cited by 164
Self-citationMELBYE, M., BIGGAR, R. J., EBBESEN, P., NEULAND, C., GOEDERT, J. J., FABER, V., LORENZEN, I., SKINHØJ, P., GALLO, R. C., & BLATTNER, W. A. (1986) · Annals of Internal Medicine · doi:10.7326/0003-4819-104-4-496 · Cited by 162
Yamamoto, J. K., Barré‐Sinoussi, F., Bolton, V., et al. (1986) · Journal of Interferon Research · doi:10.1089/jir.1986.6.143 · Cited by 143
Persistent Noncytopathic Infection of Normal Human T Lymphocytes with AIDS-Associated Retrovirus
Hoxie, J. A., Haggarty, B., Rackowski, J. L., Pillsbury, N., & Levy, J. A. (1985) · Science · doi:10.1126/science.2994222 · Cited by 143
Tumor promoter, TPA, enhances replication of HTLV-III/LAV
Harada, S., Koyanagi, Y., Nakashima, H., Kobayashi, N., & Yamamoto, N. (1986) · Virology · doi:10.1016/0042-6822(86)90451-4 · Cited by 131
Deitch, R. (1983) · The Lancet · doi:10.1016/s0140-6736(83)92858-1 · Cited by 124
Clinical implications of recent developments in gastric cancer pathology and epidemiology.
Banham, S., Dorward, A., Hutcheon, A., et al. (1985) · PubMed · Cited by 118
Ríos, A., Mansell, P. W. A., Newell, G. R., Reuben, J. M., Hersh, E. M., & Gutterman, J. U. (1985) · Journal of Clinical Oncology · doi:10.1200/jco.1985.3.4.506 · Cited by 99
The natural history of human T lymphotropic virus-III infection: the cause of AIDS.
Melbye, M. (1986) · BMJ · doi:10.1136/bmj.292.6512.5 · Cited by 91
Natural killer cells in intravenous drug abusers with lymphadenopathy syndrome.
Poli, G., Introna, M., Zanaboni, F., Peri, G., Carbonari, M., Aiuti, F., Lazzarin, A., Moroni, M., & Mantovani, A. (1985) · PubMed Central · Cited by 69
Self-citationDirect and Cell-Mediated Effects of Interferon-α and -γ on Cells Chronically Infected with HTLV-III
Dolei, A., Fattorossi, A., D'Amelio, R., Aiuti, F., & DIANZANI, F. (1986) · Journal of Interferon Research · doi:10.1089/jir.1986.6.543 · Cited by 34
Cited by
The Immunopathogenesis of Human Immunodeficiency Virus Infection
Epstein, F. H., Pantaleo, G., Graziosi, C., & Fauci, A. S. (1993) · New England Journal of Medicine · doi:10.1056/nejm199302043280508 · Cited by 1,189
Self-citationPathogenesis of human immunodeficiency virus infection
Levy, J. A. (1993) · Microbiological Reviews · doi:10.1128/mr.57.1.183-289.1993 · Cited by 839
Host-directed therapies for bacterial and viral infections
Kaufmann, S. H. E., Dorhoi, A., Hotchkiss, R. S., & Bartenschlager, R. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.162 · Cited by 831
Multifactorial Nature of Human Immunodeficiency Virus Disease: Implications for Therapy
Fauci, A. S. (1993) · Science · doi:10.1126/science.8235617 · Cited by 776
Self-citationMolecular Targets for AIDS Therapy
Mitsuya, H., Yarchoan, R., & Broder, S. (1990) · Science · doi:10.1126/science.1699273 · Cited by 732
Metadata
- Authors
- Poli, G., Orenstein, J. M., Kinter, A., Folks, T. M., & Fauci, A. S.
- Venue
- Science
- Published
- 1989-05-05
- Volume
- 244
- Issue
- 4904
- Pages
- 575-577
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2053905319
- Cited by
- 328
- References
- 43
- FWCI
- 9.32
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.